Introduced January 13, 2026
SB82
Log in to followAN ACT relating to administrative regulations for medications for substance use disorder and declaring an emergency.
Create a new section of KRS Chapter 13A to find 201 KAR 9:270 and 201 KAR 20:065 deficient and void; create new sections of KRS Chapters 311, 313, 314, and 315 to establish that the State Board of Medical Licensure, Board of Dentistry, Kentucky Board of Nursing, and Kentucky Board of Pharmacy shall not promulgate administrative regulations that restrict or limit the prescribing, dispensing, or administering of buprenorphine-mono-product, buprenorphine-combined-with-naloxone, or any other Schedule III, IV, or V medication approved by the United States Food and Drug Administration for the treatment of a substance use disorder; EMERGENCY.
Plain-language summary
This bill would strike down two existing state regulations and prevent Kentucky's medical licensing boards from creating rules that limit how doctors, dentists, nurses, and pharmacists can prescribe or dispense certain medications used to treat substance use disorder, including buprenorphine. It is filed as an emergency measure, meaning it would take effect immediately if signed into law. The goal is to remove regulatory barriers that the bill finds unlawfully restrict access to FDA-approved treatment medications. Who it may affect: Kentuckians seeking treatment for substance use disorder, as well as physicians, dentists, nurses, and pharmacists who prescribe or dispense these medications.
Open official bill text (PDF)·Report a problem with the summary
Legislative History
Primary Sponsor
Julie Raque Adams
Senator · Senate District 36
Co-sponsors (5)
Scott Madon
Senator · Senate District 29
Mike Nemes
Senator · Senate District 38
Steve Rawlings
Senator · Senate District 11
Aaron Reed
Senator · Senate District 07
Lindsey Tichenor
Senator · Senate District 06
Bill Text Versions
Something wrong on this page? Tell us
